Home
Companies
argenx
Clinical Trials

Clinical Trials Related to argenx

Related studies linked through entity extraction aliases.

A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

Status: WITHDRAWN
Phase: PHASE2

A Study of Cusatuzumab Plus Azacitidine in Japanese Participants With Newly Diagnosed Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome Who Are Not Candidates for Intensive Treatment

Status: COMPLETED
Phase: PHASE1

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Status: COMPLETED
Phase: PHASE3

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Status: COMPLETED
Phase: PHASE3

Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Efgartigimod Co-administered Subcutaneously With rHuPH20 in Healthy Subjects

Status: COMPLETED
Phase: PHASE1

A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness.

Status: COMPLETED
Phase: PHASE3

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

Status: COMPLETED
Phase: PHASE3

IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers

Status: COMPLETED
Phase: PHASE1

A Study to Compare the PK, PD and Safety and Tolerability of a SC With an IV Formulation of ARGX-113 in Healthy Male Subjects

Status: COMPLETED
Phase: PHASE1

A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus

Status: COMPLETED
Phase: PHASE2

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP

Status: COMPLETED
Phase: PHASE2

A Study of ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

Status: COMPLETED
Phase: PHASE2

A Study of ARGX-110 in Patients With Nasopharyngeal Carcinoma (NPC)

Status: COMPLETED
Phase: PHASE1

A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer.

Status: COMPLETED
Phase: PHASE1

A Study of ARGX-110 in Participants With Advanced Malignancies

Status: COMPLETED
Phase: PHASE1/PHASE2